ArticleBone marrow transplantation2022
HLA-identical related hematopoietic stem cell transplantation in severe sickle cell disease: age is not a barrier to successful outcome.
Mohsen Alzahrani, Moussab Damlaj, Mohammed Essa, Bader Alahmari, Ahmed Alaskar, Ayman Hejazi, Enas Basher, Husam Alsadi, Mazin Ahmed, Rodaina Abujoub and 6 more
Abstract readLetter
In one paragraphArticle in Bone marrow transplantation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
16 authors.
Mohsen AlzahraniDepartment of Oncology & Department of Pediatric Hematology/Oncology. Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia. alzahranimo5@ngha.med.sa.ORCID http://orcid.org/0000-0002-9174-5803 Ayman HejaziDepartment of Oncology & Department of Pediatric Hematology/Oncology. Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
Enas BasherDepartment of Oncology & Department of Pediatric Hematology/Oncology. Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
Husam AlsadiDepartment of Oncology & Department of Pediatric Hematology/Oncology. Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
Mazin AhmedDepartment of Oncology & Department of Pediatric Hematology/Oncology. Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
Rodaina AbujoubDepartment of Oncology & Department of Pediatric Hematology/Oncology. Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
Samer GhaziDepartment of Oncology & Department of Pediatric Hematology/Oncology. Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
Heba AlshobakiDepartment of Oncology & Department of Pediatric Hematology/Oncology. Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
Hind SalamaDepartment of Oncology & Department of Pediatric Hematology/Oncology. Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
Giamal GmatiDepartment of Oncology & Department of Pediatric Hematology/Oncology. Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Anemia, Sickle CellHematopoietic Stem Cell TransplantationHLA AntigensHumansHLA Antigens
What OpenQuestion holds
Textmetadata
Read underepoch 390